Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2087241000001111 | Tepotinib hydrochloride | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2087251000001114 | Tepotinib hydrochloride (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tepotinib hydrochloride | Is a | Substance with protein kinase inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tepotinib 225mg tablets | Has specific active ingredient | False | Tepotinib hydrochloride | Inferred relationship | Existential restriction modifier | |
| Tepmetko 225mg tablets (Merck Serono Ltd) | Has specific active ingredient | False | Tepotinib hydrochloride | Inferred relationship | Existential restriction modifier | |
| Tepotinib 225mg tablets 60 tablet | Has specific active ingredient | False | Tepotinib hydrochloride | Inferred relationship | Existential restriction modifier | |
| Tepmetko 225mg tablets (Merck Serono Ltd) 60 tablet | Has specific active ingredient | False | Tepotinib hydrochloride | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR